Search

Introduction: Ixodes ricinus, the castor bean tick, is the most prevalent tick species in Europe. It favours habitats such as shrubs, deciduous and mixed forests, but can also be found in urban environments. Due to its high vector competence, it is of enormous veterinary as well as medical importance, transmitting tick-borne encephalitis (TBE) virus, Borrelia burgdorferi s. l., the causative agent of lyme borreliosis, Rickettsia spp. and Anaplasma phagocytophilum amongst many other pathogens. In Kosovo, I. ricinus is the predominant species and a few studies, mostly based on human and animal seroprevalences, indicate the circulation of tick-borne pathogens. However, data on pathogens in I. ricinus are scarce in Kosovo, particularly in urban settings. This study aimed to provide first insights into the circulation of tic-kborne pathogens in I. ricinus from urban and peri-urban areas in Kosovo., Methods: Urban and peri-urban areas were sampled by flagging 150 m transects. In total, 197 ticks were morphologicaly identified as I. ricinus, and consequently DNA and RNA were isolated. All individuals were screened for the presence of tick-borne pathogens by using reverse line blotting (RLB) hybridisation., Results: DNA of nine different pathogens from four genera including Borrelia spp., Rickettsia spp., Anaplasma spp. and Babesia spp. was detected in 60 (33.5%) specimens. The most frequently detected pathogens were Rickettsia spp. (16.2%), followed by Borrelia spp. (11.7%). Altogether, 54 single infections, 11 double infections and 1 triple infection were observed., Conclusions: We provide first data on genotyping of B. burgdorferi sensu lato as well as the detection of Anaplasma, Babesia and Rickettsia from I. ricinus in this country. The data underline that particularly recreational (peri-)urban areas could facilitate the spillover of zoonotic tick-borne pathogens to humans in Kosovo and provide baseline data for future surveys., (© 2024 The Author(s). Zoonoses and Public Health published by Wiley‐VCH GmbH.)

Cancer remains a significant health challenge globally, requiring the development of targeted chemotherapeutics capable of specifically inhibiting cancer cell growth. Angiogenesis is one of the key features of tumor growth and metastasis and is, therefore, an important target for the treatment of many tumors. The vascular endothelial growth factor (VEGF) signaling pathway has proven to be a promising lead in anticancer therapy due to the central role it plays in tumor angiogenesis. Vascular endothelial growth factor receptor-2 (VEGFR-2) is a key mediator in the signaling pathway regulating angiogenesis. Targeting VEGFR-2 may disrupt angiogenesis, leading to a reduction in tumor blood supply and tumor progression. The design, synthesis, and assessment of novel VEGFR-2 inhibitor derivatives are the focus of this study, with particular emphasis on incorporating the pyrazole-thiadiazol pharmacophore into the molecular structure. Taking advantage of the pharmacophoric properties of pyrazole and 1,3,4-thiadiazol, compounds with different substituents in the main structure were designed and synthesized. The compounds were also evaluated for antiproliferative activity against cancer cell lines. Compound 4e demonstrated the highest activity among all compounds, with an IC 50 of 9.673 ± 0.399 μM against HT-29 cells and 23.081 ± 0.400 μM against NIH3T3 cells. To further support the inhibitory activity of compound 4e , an in silico study was performed. Compound 4e demonstrated strong binding to the active site of VEGFR-2 in molecular docking studies, forming hydrogen bonds with key amino acid residues. The stability of the compound in the enzyme's active site was demonstrated through molecular dynamics simulations., (© 2024 Walter de Gruyter GmbH, Berlin/Boston.)